Calendar Recursion Pharmaceuticals, Inc.

Equities

RXRX

US75629V1044

Market Closed - Nasdaq 21:00:00 24/06/2024 BST 5-day change 1st Jan Change
9.34 USD +5.54% Intraday chart for Recursion Pharmaceuticals, Inc. -0.32% -5.27%

Chart calendar Recursion Pharmaceuticals, Inc.

7.oCf4_p96IpwGMG74C6iZb_D-MHMEwmSmN4C_jqAt0ck.4hesh-cpUa1sBFqJfu_wAd2cCQRonVPUdNfm2slshrPQbJmXzQoT2D9WAQ~1dcd84e9bddff548e7ac20f47d6e4795

Upcoming events on Recursion Pharmaceuticals, Inc.

25/06/2024 Morgan Stanley Life Sciences AI Summit
05/08/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)
03/03/2025 Q4 2024 Earnings Release (Projected)
06/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Recursion Pharmaceuticals, Inc.

09/06/2024 Goldman Sachs Global Healthcare Conference
05/06/2024 15:30 Jefferies Global Healthcare Conference
03/06/2024 15:00 Annual General Meeting
20/05/2024 19:30 J.P. Morgan Global Technology, Media and Communications Conference
14/05/2024 23:00 BofA Securities Health Care Conference
09/05/2024 22:00 Q1 2024 Earnings Call
09/05/2024 21:01 Q1 2024 Earnings Release
08/04/2024 15:15 Needham Healthcare Conference
18/03/2024 KeyBanc Life Sciences & MedTech Forum
11/03/2024 18:00 Leerink Partners Global Biopharma Conference
05/03/2024 19:00 KeyBanc Emerging Technology Summit
04/03/2024 21:25 Morgan Stanley Technology, Media & Telecom Conference
27/02/2024 22:00 Q4 2023 Earnings Call
27/02/2024 21:05 Q4 2023 Earnings Release
16/01/2024 14:30 Needham Growth Conference
08/01/2024 15:30 JPMorgan Healthcare Conference
14/11/2023 08:00 Jefferies London Healthcare Conference
09/11/2023 12:58 Q3 2023 Earnings Release
27/09/2023 14:30 Goldman Sachs Global Sustainability Forum
26/09/2023 16:05 Cantor Global Healthcare Conference

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
3,96


10,2
12,4
-17.66%
39,8
51,2
-22.25%
44,6
52,1
-14.47%

58,9

EBITDA
Million USD
Released
Forecast
Spread
0,00


-174
-175
0.11%
-234
-256
8.74%
-326
-307
-6%

-410

EBIT
Million USD
Released
Forecast
Spread
0,00


-183
-174
-4.89%
-246
-227
-8.46%
-350
-342
-2.41%

-426

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-186
-163
-14.4%
-239
-216
-11.13%
-332
-329
-0.81%

-392

Net income
Million USD
Released
Forecast
Spread
-87,0


-186
-177
-5.45%
-239
-226
-6.11%
-328
-333
1.49%

-401

EPS
USD
Released
Forecast
Spread
-5,99


-1,49
-1,20
-24.25%
-1,36
-1,39
2.44%
-1,58
-1,66
5.01%

-1,64

Announcement Date03/03/2123/03/2227/02/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
5,33
84,0
-93.65%
7,67
5,40
42.11%
13,2
6,85
92.12%
13,7
24,0
-43.02%
12,1
13,2
-7.75%
11,0
11,9
-7.54%
10,5
12,9
-18.16%
10,9
20,4
-46.49%
13,8
13,1
5.57%

13,8


13,9


15,4


15,1


15,4

EBITDA
Million USD
Released
Forecast
Spread






-59,6
-75,0
20.55%



-66,1
-113
41.21%
-76,2
-63,7
-19.58%



-91,4
-85,5
-6.87%

-91,3


-89,0


-88,3


-182


-199


-203

EBIT
Million USD
Released
Forecast
Spread
-56,0
-52,0
-7.66%
-66,2
-65,6
-0.92%
-62,6
-66,9
6.5%
-61,0
-49,8
-22.52%
-69,9
-63,0
-10.89%
-81,7
-73,1
-11.82%
-99,6
-81,9
-21.57%
-98,9
-87,9
-12.52%
-96,3
-100
3.73%

-102


-106


-131


-154


-156

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread



-65,6
-57,0
-15.02%
-60,4
-61,0
0.91%
-57,5
-13,0
-342.25%
-65,3
-62,0
-5.37%
-76,7
-69,0
-11.2%
-93,0
-82,0
-13.44%
-94,6
-94,4
-0.24%
-92,2
-106
13.06%

-97,0


-98,0


-104







Net income
Million USD
Released
Forecast
Spread
-56,0
87,3
-164.12%
-65,6
-60,6
-8.27%
-60,4
-63,1
4.21%
-57,5
-45,9
-25.25%
-65,3
-60,2
-8.48%
-76,7
-70,6
-8.62%
-93,0
-77,5
-20.01%
-93,0
-96,7
3.87%
-91,4
-98,9
7.63%

-96,9


-97,3


-124


-154


-156

EPS
USD
Released
Forecast
Spread
-0,33
0,51
-164.71%
-0,38
-0,35
-10.1%
-0,35
-0,36
3.22%
-0,30
-0,25
-20%
-0,34
-0,34
-0.43%
-0,38
-0,37
-3.55%
-0,43
-0,38
-12.99%
-0,42
-0,45
6.69%
-0,39
-0,42
6.25%

-0,40


-0,39


-0,48


-0,67


-0,67

Announcement Date10/05/2209/08/2208/11/2227/02/2308/05/2308/08/2309/11/2327/02/2409/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RXRX Stock
  4. Calendar Recursion Pharmaceuticals, Inc.